Literature DB >> 21526464

[Factors that influence clinical outcome following autologous chondrocyte implantation for cartilage defects of the knee].

P Niemeyer1, G M Salzmann, A Hirschmüller, N P Südkamp.   

Abstract

AIM: Since its introduction in 1994, autologous chondrocyte implantation (ACI) has become an established surgical treatment for symptomatic isolated cartilage defects of the knee. Success rates vary between 80 and 95% and the clinical outcome seems to depend on various individual factors. The aim of the present review article is to summarise factors that affect clinical outcome following ACI for treatment of symptomatic cartilage defects of the knee based upon the scientific literature available on this topic.
METHODS: The present publication represents a non-systematic review including publications which were considered relevant describing factors that influence clinical outcome following ACI for treatment of symptomatic full thickness cartilage defects of the knee. In order to identify relevant literature concerning complications following cartilage repair, medical databases including "medline", "ovid" and "web of science" were searched for the terms "autologous chondrocyte implantation", "autologous chondrocyte transplantation", "prognostic factor", "clinical outcome", "cartilage repair", "cartilage defect" and "cartilage regeneration". The literature search was performed in April 2010.
RESULTS: Factors that influence clinical outcome following ACI for treatment of cartilage defects of the knee include patient-specific parameters on the one hand, such as body mass index, nicotine abusus, patients age, prior surgical treatment, duration of symptoms and more, and defect characteristics such as containment, defect location, defect size, number of defects treated, on the other hand. Furthermore, surgical technique, cell quality and rehabilitation seem to significantly influence the clinical outcome following autologous chondrocyte implantation. Among all factors identified as relevant for clinical outcome, some of these parameters are fixed and cannot be changed by either the surgeon nor the patient, while others can be influenced and even changed during the treatment and rehabilitation of a patient who underwent ACI.
CONCLUSION: Knowledge of all relevant parameters that influence clinical outcome following ACI is essential in order to achieve an optimal clinical outcome in patients with cartilage defects of the knee. This paper presents a review of the scientific literature available which focuses on the questions as to what parameters influence the outcome of a patient following ACI for treatment of cartilage defects of the knee. No isolated factors could be identified that influence the outcome following ACI alone, but it seems that clinical outcome is influenced by many different parameters. These parameters should be considered carefully, at the time of decision about what kind of treatment is applied. Furthermore, the patient should be informed especially about those parameters which can be influenced by him-/herself in order to create good prerequisites for the surgical treatment. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21526464     DOI: 10.1055/s-0030-1270894

Source DB:  PubMed          Journal:  Z Orthop Unfall        ISSN: 1864-6697            Impact factor:   0.923


  10 in total

1.  Correlation of synovial cytokine expression with quality of cells used for autologous chondrocyte implantation in human knees.

Authors:  Hagen Schmal; Alexander T Mehlhorn; David Dovi-Akue; Jan M Pestka; Norbert P Südkamp; Philipp Niemeyer
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-12

Review 2.  Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives.

Authors:  Andre F Steinert; Lars Rackwitz; Fabian Gilbert; Ulrich Nöth; Rocky S Tuan
Journal:  Stem Cells Transl Med       Date:  2012-02-22       Impact factor: 6.940

3.  Time Matters: Knee Cartilage Defect Expansion and High-Grade Lesion Formation while Awaiting Autologous Chondrocyte Implantation.

Authors:  Robert J Pettit; Joshua S Everhart; Alex C DiBartola; Ryan E Blackwell; David C Flanigan
Journal:  Cartilage       Date:  2021-12-11       Impact factor: 3.117

4.  Is the transplant quality at the time of surgery adequate for matrix-guided autologous cartilage transplantation? A pilot study.

Authors:  Johannes Zellner; Peter Angele; Florian Zeman; Richard Kujat; Michael Nerlich
Journal:  Clin Orthop Relat Res       Date:  2013-09       Impact factor: 4.176

5.  A Registry for Evaluation of Efficiency and Safety of Surgical Treatment of Cartilage Defects: The German Cartilage Registry (KnorpelRegister DGOU).

Authors:  Julia Maurer; Birgit Grotejohann; Carolin Jenkner; Carla Schneider; Thomas Flury; Adrian Tassoni; Peter Angele; Jürgen Fritz; Dirk Albrecht; Philipp Niemeyer
Journal:  JMIR Res Protoc       Date:  2016-06-29

6.  Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles.

Authors:  Charlotte H Hulme; Emma L Wilson; Mandy J Peffers; Sally Roberts; Deborah M Simpson; James B Richardson; Pete Gallacher; Karina T Wright
Journal:  Arthritis Res Ther       Date:  2017-06-30       Impact factor: 5.156

7.  Repair of osteochondral defects with in vitro engineered cartilage based on autologous bone marrow stromal cells in a swine model.

Authors:  Aijuan He; Lina Liu; Xusong Luo; Yu Liu; Yi Liu; Fangjun Liu; Xiaoyun Wang; Zhiyong Zhang; Wenjie Zhang; Wei Liu; Yilin Cao; Guangdong Zhou
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

8.  Co-culture of hWJMSCs and pACs in double biomimetic ACECM oriented scaffold enhances mechanical properties and accelerates articular cartilage regeneration in a caprine model.

Authors:  Yu Zhang; Chunxiang Hao; Weimin Guo; Xiaoyu Peng; Mingjie Wang; Zhen Yang; Xu Li; Xueliang Zhang; Mingxue Chen; Xiang Sui; Jiang Peng; Shibi Lu; Shuyun Liu; Quanyi Guo; Qing Jiang
Journal:  Stem Cell Res Ther       Date:  2020-05-19       Impact factor: 6.832

9.  Histone hypo-acetylation of Sox9 mediates nicotine-induced weak cartilage repair by suppressing BMSC chondrogenic differentiation.

Authors:  Kai Tie; Min Wu; Yu Deng; Yinxian Wen; Liaobin Chen; Hui Wang
Journal:  Stem Cell Res Ther       Date:  2018-04-10       Impact factor: 6.832

Review 10.  Association of Nicotine with Osteochondrogenesis and Osteoarthritis Development: The State of the Art of Preclinical Research.

Authors:  Xiaoyu Cai; Liang Gao; Magali Cucchiarini; Henning Madry
Journal:  J Clin Med       Date:  2019-10-16       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.